TCBWF

0.00180.00%
BL

Bryan Leland Kobel

CEO & Director

Mr. Bryan Leland Kobel serves as Chief Executive Officer at TC Biopharm Limited and serves as its Director. Mr. Kobel serves as Chief Executive Officer of TC Biopharm (Holdings) Plc since June 2021 and serves as Director. He joined TC BioPharm in June 2021. Prior to joining TC BioPharm he served as Managing Director at EF Hutton from October 2020 as the head of healthcare investment banking. He served as Managing Director of Investment Banking and Capital Markets at The Alberleen Group LLC since June 2018 to October 2020. Mr. Kobel joined the Alberleen from R.F. Lafferty & Co. where he was Head of Capital Markets focused on sourcing, structuring and institutional placement of transactions, primarily in the healthcare, technology and telecom sectors from April 2017 to June 2018. He was Managing Director for Equity Capital Markets at Laidlaw & Company (UK) Ltd. from March 2012 to April 2017. Mr. Kobel served as the Vice President of Capital Markets at Laidlaw & Company (UK) Ltd. Mr. Kobel holds a BA degree from Franklin & Marshall College and held the FINRA licenses Series 7, 63, 82, 79 and 24.

Positions